Daiichi Sankyo Nordics ApS: Financial statements 2022
CVR: 39371049
Source: annual report 2022, Danish Business Authority
01/04/2021 – 31/03/2022
Daiichi Sankyo Nordics ApS (CVR 39371049) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 35,620,722 and a net result of DKK 46,355 compared with DKK 846,325 the year before. That is an increase of 30% compared with the year before. Equity in the 2022 report amounted to DKK 3,383,297. The solvency ratio was 6.9%. The company had 22 employees in the financial year.
- Gross Profit
- DKK 35,620,722
- Profit/Loss
- DKK 46,355
- Equity
- DKK 3,383,297
- Total Assets
- DKK 48,945,341
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 35.6M | 46K | 3.4M | 22 |
| 2021 | - | 27.4M | 846K | 3.3M | 16 |
| 2020 | - | 20.6M | 1.2M | 2.5M | 16 |
| 2019 | - | 2.9M | 253K | 1.3M | 2 |
Official annual report
Keep an eye on Daiichi Sankyo Nordics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of August 3, 2022, Karin Margaretha Heisterberg has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of August 3, 2022, Tim Ellmers has left the board of directors of Daiichi Sankyo Nordics ApS.
About Daiichi Sankyo Nordics ApS
Daiichi Sankyo Nordics ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Daiichi Sankyo Oncology Nordics ApS. The management consists of Christophe Tiberghien. The board consists of Christophe Tiberghien, Jacob Wessel-Tolvig and Karin Margaretha Heisterberg. The company is owned by Daiichi Sankyo Oncology Europe GmbH. The company has 32 employees (2026). In 2026, the company reported a gross profit of DKK 83,558,930 and a net result of DKK 17,269,490 compared with DKK 9,020,707 the year before. Equity in the 2026 report amounted to DKK 40,346,412.
